GlassScriptPhysician profile
Christopher D Miller
NPI 1184983629
$745.28
in general payments reported to CMS, 2019-2025
18 companies · $22.39 in 2025
The $22.39 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709 · 2023: $14.15 · 2025: $22.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $170.92 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $138.72 | 2019 | |
| Smith+Nephew, INC. | $85.07 | 2019 | |
| Eisai INC. | $57.15 | 2019 | |
| Novo Nordisk INC | $55.77 | 2019 | |
| Amgen INC. | $38.06 | 2019 | |
| Valeritas, INC. | $27.34 | 2019 | |
| Inspire Medical Systems, INC. | $22.39 | 2025 | Inspire |
| Phadia US INC. | $19.28 | 2019 | |
| Astellas Pharma US INC | $17.48 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.97 | 2019 | |
| Sanofi Pasteur INC. | $15.66 | 2019 | |
| Acadia Pharmaceuticals INC | $14.15 | 2023 | Nuplazid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.12 | 2019 | |
| Merck Sharp & Dohme LLC | $13.85 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.47 | 2019 | |
| Shire North American Group INC | $13.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.